TABLE 3

Parent ions and major fragment ions of clofarabine and authentic reference metabolites following LC-MS/MS analyses under negative mode of detection In parenthesis are metabolites observed from in vitro hepatocyte studies. The most intense ions are presented in bold.


Peak

Description

(M–H)-m/z

Major Fragment Ions
1–6 Unknown N.S. N.A.
7 2-Chloroadenine 168 132
8 Unknown (rat) 343 N.D.
9a 6-Ketoclofarabine 303 133, 169, 189, 225, 235, 265, 283
9b Clofarabine phosphate 382 79, 168, 195, 213
9c Unknown (rat) 392 N.D.
10 Unknown N.D. N.D.
11 Carboxy- or methoxy-clofarabine 316 132, 168, 198
12 Clofarabine-glucuronide (rat and dog) 478 N.D.
13a Clofarabine-sulfate 382 168, 213, 362
13b Clofarabine-glucuronide (rat) 478 N.D.
14 Clofarabine-sulfate (rat, dog, human) 382 168, 213, 362
15a Clofarabine 302 132, 168, 188, 198, 224, 228, 234, 246, 264, 282
16 Unknown N.S. N.A.
17
Unknown
N.S.
N.A.
  • N.S., not studied; N.A., not applicable; N.D., not detected.

  • a Denotes that peak is parent clofarabine